On behalf of the Organizing and Programme Committees, it is with great pleasure that we announce our 5th Trisomy 21 Research Society (T21RS) International Conference, to be held from 5th of June – 8th of June 2024 in Rome, Italy. It will also be the 10th Anniversary of the T21RS. We hope to see you there!
The T21RS meetings are devoted to advancing both basic and clinical science in Down syndrome and related areas. The major goals of the meeting are to 1) support the dissemination and discussion of the latest advances in Down syndrome research 2) facilitate collaboration among researchers and 3) utilize new scientific knowledge to develop improved treatments.
Thus, the Scientific Programme Committee is requesting proposals for symposia in basic, clinical, and translational research in Down syndrome. We welcome symposium proposals from multiple disciplines, including, but not limited to, the following themes:
- Genomic and Epigenetic Mechanisms
Genetics, genomics, epigenetics, other -omics (transcriptome, metabolome, proteome, exposome, single-cell etc.), 3D genome organisation, multiomic modelling
- Molecular and Cellular Mechanisms
Neurobiological, immunological, metabolism, synaptic mechanisms, plasticity, neuronal networks, etc.
- Experimental Models
Animal models, cellular models, organoids, stem cells and reprogramming, etc.
- Cognition and Behavior
Clinical and preclinical studies on cognition and behaviour, intellectual disability, language, behavior, emotion, executive functions, sex-specific differences, neuropsychological evaluation tool
- Neurodegeneration and Ageing
Alzheimer disease in Down syndrome, neuropathology, immunosenescence, cognitive decline, etc.
Neuropathology, neurogenesis, cell proliferation and differentiation, synaptogenesis, nervous system patterning, etc.
- Co-occurring Illnesses
Cancer/ leukemia, psychiatric disorders, metabolic disorders, sensory disorders, cardiovascular diseases, etc.
- Therapeutic intervention
Pharmacological/non-pharmacological interventions, neurotherapy, preclinical drug development, experimental therapeutics, clinical trials, biomarkers
- Diagnosis and Evaluation
Biomarkers, neuroimaging, outcome measures
- DS international capacity building
Biobanking, data management/sharing, novel AI and computational approaches.
- DS inclusivity and society
Ethics and social aspects related to DS
We encourage both established and junior investigators to contribute to the program of the meeting. We welcome preclinical and clinical science, ranging from molecular biology to human research, and especially topics that bridge scientific disciplines.
A descriptive symposium title.
A short outline describing the topic and its relevance to the field (max. 2000 characters with spaces, about 250 words).
Four lecture titles and speaker information. *
* Please confirm that speakers can attend in person prior to the submission.
This is an international meeting, and we value a diverse pool of speakers, so please consider speakers from various geographical locations and ethnicity. Gender balance is also important. Preference will be given to proposals that include at least one presentation from a junior investigator (please note this in your outline). We also encourage to include one speaker outside the field of Down syndrome, whose research is of relevance for the Down syndrome research community. The program committee may also modify accepted proposals for content and will reach out to proposers if needed.
We encourage you to help us make the 2024 T21RS meeting in Rome a success! Proposals will be accepted only from T21RS members. If you are not a T21RS member, please join at www.t21rs.org/become-a-member.
Submit your proposal before 12th of November
On behalf of the Scientific Program Committee,
Trisomy 21 Research Society